Early-phase clinical trials
Platform for early-phase clinical trials
A platform for conducting Phase I/IIa clinical trials has been set up that performs studies, including first-in-human studies, in collaboration with industrial partners, INCa, and the American National Cancer Institute (NCI). It brings together the capabilities of a dedicated LYSARC team, as well as those of a network of LYSA centres of expertise, in particular the INCa-accredited early-phase centres, otherwise known as “CLIP2” centres. There are between 8 and 12 LYSA centres for Phase I trials and between 20 and 30 centres for Phase IIa trials.